1. CMS proposed 2017 physician fee schedule eliminates moderate sedation from endoscopic procedures: 6 things to know
Click here
2. Boston Scientific hedges bets on endoscopic division, analysts project $5B valuation: 6 things to know
Click here
3. Valeant could sell Salix Pharmaceuticals to Takeda for $10B in cash grab: 7 things to know
Click here
4. The 16 items on MACRA’s GI measure set for 2017
Click here
5. Inflammatory bowel disease 3 times more common than previous estimates: 5 takeaways
Click here
More articles on gastroenterology/endoscopy:
Boston Scientific hedges bets on endoscopic division; Allergan selects IBS spokesperson & more: 4 GI company key notes
Metastatic tumor-destroying vaccine for colon cancer patients to begin phase II trial: 6 key notes
Boston Scientific closes EndoChoice purchase: 4 things to know
